Last updated: February 3, 2025
Sponsor: Xuanwu Hospital, Beijing
Overall Status: Active - Recruiting
Phase
N/A
Condition
Epilepsy
Treatment
Temporal Interference
Clinical Study ID
NCT06663969
2024-258-002
Ages 14-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Clinical diagnosis of drug-resistant epilepsy;
No severe systemic diseases;
Implantation of stereotactic electrodes;
Agreement to participate in this study and signs the informed consent form.
Exclusion
Exclusion Criteria:
- Hematoma at the scalp electrode site or fluid accumulation under the electrode afterintracranial electrode placement.
Study Design
Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Temporal Interference
Phase:
Study Start date:
November 04, 2024
Estimated Completion Date:
October 31, 2025
Study Description
Connect with a study center
Xuanwu Hospital,Capital Medical University
Beijing, Beijing 100053
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.